CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Biomarkers for Event-driven PrEP Adherence [Phase 4]
Summary
Phase 4 clinical trial update reporting results on biomarkers to monitor adherence to event-driven HIV pre-exposure prophylaxis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19